~~<i id='38809B8088'><strike id='38809B8088'><tt id='38809B8088'><pre id='38809B8088'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：focus 2025-10-01 14:19:53 - browse：5

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Why workplace violence is so common in health care

hotspot

leisure time

entertainment

leisure time

focus

hotspot

NEWYORK--NewYorkMayorEricAdamsannouncedaplanMondaytohouseasmanyas2,000migrantsonanislandintheEastRiv

WSS

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Congress likely to miss an opportunity to fix drug shortages issue

Congress: Eradicate hepatitis C and reduce the deficit

Who gets to use the title 'doctor'?

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

focus

comprehensive

hotspot

Medicare details structure of new drug price negotiation program

Democratic lawmaker calls for 'well

Drug repurposing or repositioning? The language matters

The UK government moves asylum

New air purifier tech could be key to improving indoor air quality

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

How to save PrEP access — and even expand it

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Affirmative action in medical school literally saved lives

Georgia court denies Trump's request to quash DA's 2020 election probe

leisure time

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Global childhood vaccinations edge closer to pre

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Mike Pence clashes with Tucker Carlson in Iowa

Congress likely to miss an opportunity to fix drug shortages issue

Argenx drug significantly slows progression of nerve disorder

entertainment

leisure time

focus

hotspot